National Health Investors (NYSE:NHI) Updates FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 4.430-4.440 for the period, compared to the consensus earnings per share estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Trading Up 2.6 %

NHI stock traded up $2.08 during midday trading on Friday, hitting $81.72. The stock had a trading volume of 90,310 shares, compared to its average volume of 194,262. National Health Investors has a 12-month low of $50.12 and a 12-month high of $86.13. The firm has a market cap of $3.55 billion, a PE ratio of 27.09, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. The company’s 50-day moving average price is $80.37 and its 200 day moving average price is $73.21. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. During the same period in the prior year, the firm earned $1.08 EPS. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, equities research analysts predict that National Health Investors will post 4.48 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.41%. National Health Investors’s payout ratio is currently 122.45%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on NHI. Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price for the company. Truist Financial upped their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and increased their target price for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.